People · Operator
Named in public records as an officer, director or promoter · active 2016–2024 · Biotechnology, Other, Other Technology, Other Health Care, Biotech
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Aardvark Therapeutics, Inc. | — | Biotechnology | Series C | $103.1M | $807.3M | 2024 |
| Cellares Corp | — | Other | Series C | $82.0M | $1.2B | 2021 |
| LevitasBio, Inc. | — | Other Technology | Series B | $73.8M | $96.2M | 2017 |
| ReadCoor, Inc. | — | Other Health Care | Series B | $52.4M | $593.7M | 2016 |
| SentreHEART Inc | — | Biotechnology | Series B | $51.0M | $992.2M | 2016 |
| Watchmaker Genomics, Inc. | — | Biotech | Series B | $48.3M | $712.8M | 2022 |
Victor Tong at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Victor Tong on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Richard Ferrari | 1 | 15 |
| Casey Tansey | 1 | 14 |
| Paul Meister | 1 | 12 |
| Paul Buckman | 1 | 10 |
| Russell Hirsch | 1 | 10 |
| Steven Hochberg | 1 | 9 |
| Chen Yu | 1 | 7 |
| Henry Ji | 1 | 5 |
| Justin Butler | 1 | 5 |
| Shawn Marcell | 1 | 4 |
| Paul McEwan | 1 | 3 |
| Xiangmin Cui | 1 | 3 |
| Christopher McGuinness | 1 | 3 |
| Yuh-geng Tsay | 1 | 2 |
| Phil Young | 1 | 2 |
| Stephen Picone | 1 | 2 |
| Peter Osborne | 1 | 2 |
| William Cohn | 1 | 2 |
| Zachary Hornby | 1 | 2 |
| Jerel Banks | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.